Martingale Asset Management L P Lannett CO Inc Transaction History

Martingale Asset Management L P

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	SELL	$5.75 - $7.13 $300,978 - $373,212	-52,344 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$4.9 - $7.12 $382,788 - $556,214	-78,120 Reduced 59.88%	52,344 $319,000
Q2 2020 Aug 10, 2020	SELL	$6.43 - $9.86 $90 - $138	-14 Reduced 0.01%	130,464 $947,000
Q1 2020 May 11, 2020	SELL	$6.36 - $10.05 $89,815 - $141,926	-14,122 Reduced 9.77%	130,478 $906,000
Q4 2019 Feb 10, 2020	SELL	$8.49 - $12.81 $16 - $25	-2 Reduced -0.0%	144,600 $1.28 Million
Q3 2019 Nov 13, 2019	SELL	$5.58 - $14.47 $172,991 - $448,598	-31,002 Reduced 17.65%	144,602 $1.62 Million
Q2 2019 Aug 13, 2019	BUY	$5.22 - $9.08 $69,974 - $121,717	13,405 Added 8.26%	175,604 $0
Q1 2019 May 08, 2019	BUY	$5.35 - $9.82 $122,798 - $225,398	22,953 Added 16.48%	162,199 $0
Q4 2018 Feb 11, 2019	BUY	$3.43 - $6.19 $290,942 - $525,054	84,823 Added 155.86%	139,246 $690,000
Q1 2018 May 11, 2018	BUY	$14.7 - $24.95 $73 - $124	5 Added 0.01%	54,423 $0
Q4 2017 Feb 12, 2018	BUY	$19.9 - $29.25 $32,098 - $47,180	1,613 Added 3.05%	54,418 $0
Q3 2017 Nov 13, 2017	BUY	$15.1 - $19.25 $797,355 - $1.02 Million	52,805	52,805 $975,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.